Menu
Back to Equity and Access
06/01/26

Changes in use, cost, and value of breast cancer screening among older women in the US.

Richman, Ilana; Long, Jessica B; Lindsay, Meghan E; Fendrick, A Mark; Kyanko, Kelly; Gross, Cary P. J Gen Intern Med.

Collection Topics
Big Three Conditions Business Case for Excellence Tests, Screening, and Laboratory Processes
Share

Most recent

Primary care signals and diagnostic pathways before incident heart failure: a systematic scoping review.

Jerjes, El-Osta, Jhass, et al., J Prim Care Community Health.
09/09/26 Big Three Conditions Culture, Work System, and Implementation Epidemiology

A business case for diagnostic stewardship: a practical guide from the Society for Healthcare Epidemiology of America (SHEA) Diagnostic Stewardship Special Interest Group.

Turbett, Daragiati, T. Chu, et al., Antimicrob Steward Healthc Epidemiol.
09/01/26 Business Case for Excellence Tests, Screening, and Laboratory Processes

Young women diagnosed with breast cancer: why is no one telling me to get a mammogram?

Jerome-D'Emilia, Suplee, Meyers, et al., J Nurs Scholarsh.
09/01/26 Big Three Conditions Equity, Access, and Timeliness

Summary

Diagnostic excellence requires balancing early detection with overuse, cost, and potential harms. This serial cross-sectional SEER-Medicare study examined breast cancer screening among women aged 67 years and older from 2009–2019. Screening patterns, costs, and estimated value varied by age, modality, and frequency, and ineffective screening costs accounted for over 50% of spending and over $1 billion. The results highlight the importance of aligning screening intensity with expected benefit.
Read the paper
Richman I, Long JB, Lindsay ME, et al. Changes in use, cost, and value of breast cancer screening among older women in the US. J Gen Intern Med. 2026;41(8):2204-2213.